New eye drops aim to control wet AMD without needles
Disease control
Completed
This early-phase study tested an eye drop called NT-101 in 20 people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The main goal was to check safety, and researchers also looked for signs that the drops might reduce fluid buildup and improve vis…
Phase: PHASE1, PHASE2 • Sponsor: NexThera Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:09 UTC